|
KIAA0226 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.235900E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.37760000038656E-07 |
| Normal-vs-Stage2 |
7.769800E-02 |
| Normal-vs-Stage3 |
9.755700E-02 |
| Normal-vs-Stage4 |
3.255600E-01 |
| Stage1-vs-Stage2 |
2.023400E-01 |
| Stage1-vs-Stage3 |
7.416600E-03 |
| Stage1-vs-Stage4 |
5.522900E-03 |
| Stage2-vs-Stage3 |
5.190600E-01 |
| Stage2-vs-Stage4 |
3.437000E-01 |
| Stage3-vs-Stage4 |
6.430000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.356100E-04 |
| Normal-vs-AfricanAmerican |
3.919600E-02 |
| Normal-vs-Asian |
5.233600E-02 |
| Caucasian-vs-AfricanAmerican |
9.352600E-01 |
| Caucasian-vs-Asian |
6.473700E-02 |
| AfricanAmerican-vs-Asian |
1.191600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.898400E-03 |
| Normal-vs-Female |
3.14189999994774E-06 |
| Male-vs-Female |
1.879780E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.005600E-02 |
| Normal-vs-Age(41-60Yrs) |
3.12869999996579E-06 |
| Normal-vs-Age(61-80Yrs) |
1.290500E-02 |
| Normal-vs-Age(81-100Yrs) |
8.855400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.928200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.257200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.193200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.064400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.649500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.328000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.46700000053835E-07 |
| Normal-vs-Grade 2 |
2.53220000001608E-06 |
| Normal-vs-Grade 3 |
3.005800E-02 |
| Normal-vs-Grade 4 |
2.893800E-01 |
| Grade 1-vs-Grade 2 |
9.139700E-02 |
| Grade 1-vs-Grade 3 |
2.181800E-03 |
| Grade 1-vs-Grade 4 |
4.861400E-03 |
| Grade 2-vs-Grade 3 |
5.084600E-03 |
| Grade 2-vs-Grade 4 |
1.943560E-02 |
| Grade 3-vs-Grade 4 |
6.109000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.53620000054033E-07 |
| Normal-vs-ccB subtype |
8.362500E-03 |
| ccA subtype-vs-ccB subtype |
1.786100E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.042600E-04 |
| Normal-vs-N1 |
4.066200E-01 |
| N0-vs-N1 |
6.204200E-01 |
|
|
